The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.
What the Market Looks Like?
Predicted to grow at a CAGR of 6.8% during the forecast period, the global Cell Counting marketis estimated to reach USD 12.32 billion by the end of 2023.
“By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018”
On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures.
“By application, the research applications segment is estimated to hold the largest share in 2018”
Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728
Geographical growth scenario of Cell Counting Market
North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell counting market.
Leading market players
The prominent players in the Cell Counting market include Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728
